<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): SEPTEMBER 29, 1999
------------------
IBIS TECHNOLOGY CORPORATION
---------------------------
(Exact name of registrant as specified in its charter)
MASSACHUSETTS 0-23150 04-2987600
- ------------- ---------- ----------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
32 CHERRY HILL DRIVE, DANVERS, MASSACHUSETTS 01923
- ----------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
--------------
<PAGE>
ITEM 5. OTHER EVENTS.
On September 29, 1999, the Registrant publicly disseminated a press release
announcing its planned expansion of its SIMOX wafer production capacity,
personnel and facilities.
The Registrant plans to manufacture three additional Ibis 1000 implanters
for internal wafer production. These implanters will be installed throughout the
next twelve months, with the first implanter scheduled to come on-line in the
first quarter of 2000. The Registrant also plans to expand its manufacturing and
engineering facility by approximately 10,000 square feet, hire approximately 40
engineering and skilled technical personnel and complete a new class 10
cleanroom over the next several quarters.
The information contained in the press release is incorporated herein by
reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibit.
99.1 The Registrant's Press Release dated September 29, 1999.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
-----------------------------------------
(Registrant)
Date: October 1, 1999 /s/ Debra L. Nelson
-----------------------------------------
Debra L. Nelson, Chief Financial Officer
3
<PAGE>
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
- ------ ----------- -----------
99.1 The Registrant's Press Release 5
dated September 29, 1999
4
<PAGE>
EXHIBIT 99.1
IBIS TECHNOLOGY ANNOUNCES PLANNED EXPANSION OF
SIMOX WAFER PRODUCTION CAPACITY, PERSONNEL AND
FACILITIES
BUSINESS WIRE - SEPTEMBER 29, 1999 08:59
DANVERS, Mass.--(BUSINESS WIRE)--Sept. 29, 1999--Ibis Technology Corporation
(NASDAQ: IBIS), a leading manufacturer and supplier of SIMOX-SOI (Separation
by IMplantation of OXygen / Silicon-On-Insulator) implantation equipment and
wafers to semiconductor manufacturers, today announced its plan to
manufacture three additional Ibis 1000 implanters for internal wafer
production. These implanters will be installed for wafer production
throughout the next twelve months, the first one coming on-line in the first
quarter of 2000. The addition to Ibis Technology's SIMOX production facility
is forecasted to increase the company's capacity to produce wafers by 150
percent. The company also plans to expand its manufacturing and engineering
facility by approximately 10,000 square feet, hire approximately 40
engineering and skilled technical personnel and complete a new class 10
cleanroom over the next several quarters.
"This expansion demonstrates Ibis Technology's commitment to meeting our
customers' technology requirements, both now and in the future," said Martin
Reid, President and Chief Executive Officer of Ibis Technology. "Designed to
unify the operations and augment the company's existing manufacturing
facilities in response to the growing demand for SIMOX-SOI wafers, we are
making the key capital expenditures requisite to ramp manufacturing capacity
in order to serve the global SIMOX-SOI market - a dramatic benefit to be
realized by our customers."
SIMOX-SOI wafers are Silicon-On-Insulator wafers that enable the production
of integrated circuits which the Company believes offer significant
advantages over circuits constructed on conventional silicon or epitaxial
wafers. These advantages include improved microprocessing speed, reduced
power consumption and higher temperature operation. Ibis' SIMOX-SOI
implantation equipment consists of advanced proprietary high current Ibis
1000 oxygen implanters.
About Ibis Technology
Ibis Technology Corporation is headquartered in Danvers, Massachusetts and
maintains an office in Aptos, California. The Company is a premier
manufacturer and supplier of SIMOX-SOI implantation equipment and wafers for
the worldwide semiconductor industry.
<PAGE>
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: The statements contained in this press release that are not historical
fact are forward-looking statements based upon management's current
expectations that are subject to risks and uncertainties that could cause
actual results to differ materially from those set forth in or implied by
forward-looking statements, including, but not limited to, the impact of the
Year 2000 issue; product demand and market acceptance risks, general economic
conditions, the impact of competitive products, technologies and pricing,
equipment capacity and supply constraints or difficulties, the cyclical
nature of the semiconductor industry, and other risks described in the
Company's Securities and Exchange Commission filings.
Information about Ibis Technology Corporation and SIMOX-SOI is available on
Ibis's World Wide Web site at http://www.ibis.com.
-------------------
CONTACT: Ibis Technology Corporation
Debra L. Nelson
978-777-4247
[email protected]
or
Al Alioto
978-777-4247 or 831-661-9100
[email protected]
or
The Loomis Group, Inc.
Charla Jones
617-638-0022
[email protected]
